301 related articles for article (PubMed ID: 24797980)
41. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
42. Factors related to non-alcoholic fatty liver disease in obese children.
Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
[TBL] [Abstract][Full Text] [Related]
43. Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease - A preliminary study.
Bobrus-Chociej A; Wasilewska N; Harasim-Symbor E; Flisiak-Jackiewicz M; Wojtkowska M; Chabowski A; Lebensztejn D
Adv Med Sci; 2021 Mar; 66(1):35-40. PubMed ID: 33276220
[TBL] [Abstract][Full Text] [Related]
44. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
Wen H; Wang HJ; Dong B; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
[TBL] [Abstract][Full Text] [Related]
45. Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults.
Filardi T; Panimolle F; Tiberti C; Crescioli C; Lenzi A; Pallotta N; Morano S
J Endocrinol Invest; 2021 Jan; 44(1):105-110. PubMed ID: 32350824
[TBL] [Abstract][Full Text] [Related]
46. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
47. Serum inflammatory markers in overweight children and adolescents with non-alcoholic fatty liver disease.
Neuman G; Sagi R; Shalitin S; Reif S
Isr Med Assoc J; 2010 Jul; 12(7):410-5. PubMed ID: 20862821
[TBL] [Abstract][Full Text] [Related]
48. Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance.
Ou HY; Wu HT; Hung HC; Yang YC; Wu JS; Chang CJ
Endocrinology; 2012 Jul; 153(7):2974-84. PubMed ID: 22619360
[TBL] [Abstract][Full Text] [Related]
49. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA
Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
[TBL] [Abstract][Full Text] [Related]
50. MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents.
do Nascimento JH; Epifanio M; Soder RB; Baldisserotto M
Acad Radiol; 2013 Nov; 20(11):1436-42. PubMed ID: 24119357
[TBL] [Abstract][Full Text] [Related]
51. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.
Wang R; Yang F; Qing L; Huang R; Liu Q; Li X
Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515
[TBL] [Abstract][Full Text] [Related]
52. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
Fishbein MH; Mogren C; Gleason T; Stevens WR
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
[TBL] [Abstract][Full Text] [Related]
53. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Bartuli A; Manco M; Lopez R; Alisi A; Feldstein AE
Pediatr Res; 2010 Jun; 67(6):665-70. PubMed ID: 20496475
[TBL] [Abstract][Full Text] [Related]
54. Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease.
Kopiczko N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Nutrition; 2022 Feb; 94():111541. PubMed ID: 34974284
[TBL] [Abstract][Full Text] [Related]
55. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
Reinehr T; Schmidt C; Toschke AM; Andler W
Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
[TBL] [Abstract][Full Text] [Related]
56. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
Haukeland JW; Dahl TB; Yndestad A; Gladhaug IP; Løberg EM; Haaland T; Konopski Z; Wium C; Aasheim ET; Johansen OE; Aukrust P; Halvorsen B; Birkeland KI
Eur J Endocrinol; 2012 Mar; 166(3):503-10. PubMed ID: 22170794
[TBL] [Abstract][Full Text] [Related]
57. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
58. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
[TBL] [Abstract][Full Text] [Related]
59. Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity.
Koot BG; de Groot E; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; Jansen PL; Stoker J; Benninga MA
Obesity (Silver Spring); 2015 Jun; 23(6):1239-43. PubMed ID: 25960049
[TBL] [Abstract][Full Text] [Related]
60. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
